Nothing Special   »   [go: up one dir, main page]

GB9108047D0 - The use of pasteurella haemolytica clycoproteinase for human bone marrow haematopoietic primitive stem-cell isolation - Google Patents

The use of pasteurella haemolytica clycoproteinase for human bone marrow haematopoietic primitive stem-cell isolation

Info

Publication number
GB9108047D0
GB9108047D0 GB919108047A GB9108047A GB9108047D0 GB 9108047 D0 GB9108047 D0 GB 9108047D0 GB 919108047 A GB919108047 A GB 919108047A GB 9108047 A GB9108047 A GB 9108047A GB 9108047 D0 GB9108047 D0 GB 9108047D0
Authority
GB
United Kingdom
Prior art keywords
clycoproteinase
bone marrow
human bone
cell isolation
pasteurella haemolytica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919108047A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB919108047A priority Critical patent/GB9108047D0/en
Publication of GB9108047D0 publication Critical patent/GB9108047D0/en
Priority to CA002108565A priority patent/CA2108565A1/en
Priority to PCT/CA1991/000454 priority patent/WO1992018643A1/en
Priority to EP92901311A priority patent/EP0580581A1/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB919108047A 1991-04-16 1991-04-16 The use of pasteurella haemolytica clycoproteinase for human bone marrow haematopoietic primitive stem-cell isolation Pending GB9108047D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB919108047A GB9108047D0 (en) 1991-04-16 1991-04-16 The use of pasteurella haemolytica clycoproteinase for human bone marrow haematopoietic primitive stem-cell isolation
CA002108565A CA2108565A1 (en) 1991-04-16 1991-12-20 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions
PCT/CA1991/000454 WO1992018643A1 (en) 1991-04-16 1991-12-20 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions
EP92901311A EP0580581A1 (en) 1991-04-16 1992-11-06 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108047A GB9108047D0 (en) 1991-04-16 1991-04-16 The use of pasteurella haemolytica clycoproteinase for human bone marrow haematopoietic primitive stem-cell isolation

Publications (1)

Publication Number Publication Date
GB9108047D0 true GB9108047D0 (en) 1991-06-05

Family

ID=10693338

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919108047A Pending GB9108047D0 (en) 1991-04-16 1991-04-16 The use of pasteurella haemolytica clycoproteinase for human bone marrow haematopoietic primitive stem-cell isolation

Country Status (4)

Country Link
EP (1) EP0580581A1 (en)
CA (1) CA2108565A1 (en)
GB (1) GB9108047D0 (en)
WO (1) WO1992018643A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69432563T2 (en) * 1993-10-29 2004-02-26 Unisearch Ltd., Kensington DEVICE FOR CELL SEPARATION
EP0653492B1 (en) * 1993-11-15 2000-09-27 Canon Kabushiki Kaisha Process for obtaining individual microorganisms, and applications of that process
EP0819250B1 (en) * 1995-04-06 2006-09-20 Miltenyi Biotec Inc. Multiparameter cell separation using releasable colloidal magnetic particles
US6632620B1 (en) 2000-06-22 2003-10-14 Andrew N. Makarovskiy Compositions for identification and isolation of stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US4906571A (en) * 1986-10-06 1990-03-06 University Of Guelph Cell surface modification using a novel glycoproteinase of pasteurella haemolytica
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition
US5081030A (en) * 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices

Also Published As

Publication number Publication date
WO1992018643A1 (en) 1992-10-29
CA2108565A1 (en) 1992-10-17
EP0580581A1 (en) 1994-02-02

Similar Documents

Publication Publication Date Title
AU2117083A (en) Acrylic surgical bone cement
PL296730A1 (en) One-piece surgical instrument and method of making same
GB9216233D0 (en) Surgical instruments
EP0587413A3 (en) Surgical instruments
ZA933167B (en) Surgical instruments
EP0484671A3 (en) Endoscopic surgical instrument
EP0513471A3 (en) Surgical instrument
ZA9510147B (en) Hard tissue bone cements and substitutes
IL96352A0 (en) Hard tissue biopsy instrument
EP0589454A3 (en) Endoscopic surgical instrument
GB9113153D0 (en) Bone plate for the distal humerus
GB9109109D0 (en) Surgical instruments
HUP9900849A3 (en) Methods for preparing pharmaceutical compositions for minimizing bone loss effect of danazol
ZA908093B (en) Method for increasing the bulk of creped tissue
GB2208201B (en) Surgical instrument
EP0585168A3 (en) Composition and methods for the generation of bone
GB9108047D0 (en) The use of pasteurella haemolytica clycoproteinase for human bone marrow haematopoietic primitive stem-cell isolation
GB8402178D0 (en) Hip surgery
GB9007908D0 (en) Asthma prophylactic use of k + channel activators
GB9412983D0 (en) Novel types of medical use for amphotericin b
GB8903565D0 (en) Bone cements
AU8674891A (en) Apparatus for the removal of bone
ZA958277B (en) The fixation of long bone fractures
GB9013400D0 (en) Human bone marrow derived suppressor factor
AU632848B2 (en) Method for the suppression of bone marrow